I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Clinical trial NCT03939689 · COMPLETED

Trial details

NCT number: NCT03939689
Sponsor: Progenics Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Castration-resistant Prostate Cancer Prostatic Neoplasm Cancer of the Prostate Progressive mCRPC

Start date: 2019-05-30
Primary completion: 2023-09-21
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.